Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

765 trials

Showing 20 of 765 results

Large-scale testing (Phase 3)Looking for participantsNCT07250802
What this trial is testing

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 110
Early research (Phase 1)Study completedNCT01510951
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 9
Testing effectiveness (Phase 2)Study completedNCT02295865
What this trial is testing

Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 62
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Testing effectiveness (Phase 2)Looking for participantsNCT06912165
What this trial is testing

WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Brief Description of Focus of Study
Zhejiang Wenda Pharma Technology LTD. 140
Testing effectiveness (Phase 2)Ended earlyNCT05044234
What this trial is testing

Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 156
Not applicableStudy completedNCT04203693
What this trial is testing

Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 331
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Large-scale testing (Phase 3)Active Not RecruitingNCT06220604
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 731
Large-scale testing (Phase 3)Looking for participantsNCT06842199
What this trial is testing

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd. 383
Large-scale testing (Phase 3)Study completedNCT06108544
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Who this might be right for
Plaque Psoriasis
Takeda 1,108
Testing effectiveness (Phase 2)Study completedNCT06602219
What this trial is testing

LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 222
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Post-approval studies (Phase 4)Study completedNCT03331835
What this trial is testing

A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 210
Testing effectiveness (Phase 2)Study completedNCT00443326
What this trial is testing

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Who this might be right for
Psoriasis
Amgen 22
Testing effectiveness (Phase 2)Study completedNCT03230292
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 43
Large-scale testing (Phase 3)Study completedNCT00256139
What this trial is testing

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Who this might be right for
Moderate to Severe Psoriasis
Merck KGaA, Darmstadt, Germany 793
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Large-scale testing (Phase 3)Study completedNCT02474082
What this trial is testing

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 202
Testing effectiveness (Phase 2)Study completedNCT06109818
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 129
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation